本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cytokinetics

73.77
+0.15000.20%
盤後73.770.00000.00%19:30 EDT
成交量:172.15萬
成交額:1.28億
市值:102.56億
市盈率:-10.27
高:75.98
開:74.66
低:73.50
收:73.62
52周最高:88.31
52周最低:47.22
股本:1.39億
流通股本:1.38億
量比:1.14
換手率:1.25%
股息:- -
股息率:- -
每股收益(TTM):-7.1827
每股收益(LYR):-6.5400
淨資產收益率:-572.15%
總資產收益率:-28.09%
市淨率:-59.12
市盈率(LYR):-11.28

資料載入中...

2020/02/28

重要事件披露

Current report, items 5.02 and 9.01
2020/02/26

重要事件披露

Current report, items 8.01 and 9.01
2020/02/20

重要事件披露

Current report, item 8.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

重要事件披露

Current report, item 8.01
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/23

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, item 8.01
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/18

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/13

重要事件披露

Current report, items 1.01, 2.03, 8.01, and 9.01
2019/11/08

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/08

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/01

季度報告

Quarterly report [Sections 13 or 15(d)]